143 web-programmer-developer-"University-of-Illinois---Chicago" Fellowship positions at National University of Singapore
Sort by
Refine Your Search
-
Listed
-
Field
-
Job Description Job Alerts Link Apply now Job Title: Research Fellow (Genome Editing - Directed Evolution) Posting Start Date: 16/04/2025 Job Description: Job Description We are seeking a talented
-
for a motivated and experienced Programme Manager to join the Centre for Holistic Initiatives (CHILD) for Learning and Development, Yong Loo Lin School of Medicine, National University of Singapore. CHILD
-
desirable. Experience with Linux/Unix operating systems, high-performance computing clusters, relational database design, and web development is required. Prior experience with pathogen genomic epidemiology
-
, teaching and research relating to ethical and legal aspects of healthcare and biomedical sciences. We are responsible for the development and delivery of the Health Ethics, Law and Professionalism programme
-
. Programme Requirements The Fellow will develop and carry out the research project as outlined in the application. He or she will be expected to be in residence at CIL and during the period of the Fellowship
-
Description Duke-NUS Medical School (“Duke-NUS”) is Singapore’s only graduate academic medical school with Signature Research Programmes in Emerging Infectious Disease, Health Services and Systems Research
-
highly motivated and technically skilled Post-doctoral Research Fellow to join an interdisciplinary research programme focused on advancing mixed-mode ventilation (MMV) in the tropics. The aim is to
-
) Programme studies the causes and treatments of cancer and related diseases. The CSCB research groups have diverse programmes in both basic cancer biology and clinical-translational studies, with a special
-
) at the National University of Singapore (NUS) is a leading multi-disciplinary institute devoted to developing new paradigms for understanding biological functions in health and diseases from the perspective of cell
-
for renewal. The group is committed to discovering and developing new radiopharmaceuticals for cancer theranostics (therapeutics and diagnostics) that are clinically translatable. The team puts special emphasis